Platelet Factor 4 (PF4) in Septicaemia

Overview

Journal Infection

Date 1988 Sep 1

PMID 3063661

Citations 6

Authors

R Lorenz

M Brauer

Affiliations

Soon will be listed here.

Abstract

The plasma concentrations of platelet factor 4 were measured in ten patients with septicaemia. In the acute phase the platelet factor 4 values were elevated (27.1 +/- 20.1 ng/ml; mean +/- SD; normal values 4.7 +/- 1.2 ng/ml), and declined significantly after treatment with antibiotics and surgical therapy, respectively (10.6 +/- 7.3 ng/ml; p less than 0.005). The determination of prothrombin time, fibrinopeptide A, AT III and platelet counts demonstrated a coagulation disorder in the acute phase of septicaemia in all patients; a thrombocytopenia (less than 100,000/mm3) was observed in three cases. We suggest that the measurement of platelet factor 4 concentration could be useful as an in vivo indicator and as a follow-up parameter of increased platelet activation.

Citing Articles

Molecular RNA Correlates of the SOFA Score in Patients with Sepsis.

Meidert A, Buschmann D, Brandes F, Kanev K, Billaud J, Borrmann M Diagnostics (Basel). 2021; 11(9).

PMID: 34573990 PMC: 8468706. DOI: 10.3390/diagnostics11091649.

Fc-modified HIT-like monoclonal antibody as a novel treatment for sepsis.

Gollomp K, Sarkar A, Harikumar S, Seeholzer S, Arepally G, Hudock K Blood. 2019; 135(10):743-754.

PMID: 31722003 PMC: 7059515. DOI: 10.1182/blood.2019002329.

Platelet secretion of CXCL4 is Rac1-dependent and regulates neutrophil infiltration and tissue damage in septic lung damage.

Hwaiz R, Rahman M, Zhang E, Thorlacius H Br J Pharmacol. 2015; 172(22):5347-59.

PMID: 26478565 PMC: 5341222. DOI: 10.1111/bph.13325.

Sepsis biomarkers: a review.

Pierrakos C, Vincent J Crit Care. 2010; 14(1):R15.

PMID: 20144219 PMC: 2875530. DOI: 10.1186/cc8872.

Platelets in defense against bacterial pathogens.

Yeaman M Cell Mol Life Sci. 2009; 67(4):525-44.

PMID: 20013024 PMC: 2809947. DOI: 10.1007/s00018-009-0210-4.

References

Bick R, Bick M, Fekete L . Antithrombin III patterns in disseminated intravascular coagulation. Am J Clin Pathol. 1980; 73(4):577-83. DOI: 10.1093/ajcp/73.4.577. View

CORRIGAN Jr J, Ray W, May N . Changes in the blood coagulation system associated with septicemia. N Engl J Med. 1968; 279(16):851-6. DOI: 10.1056/NEJM196810172791603. View

Schipper H, Roos J, vd Meulen F, Ten Cate J . Antithrombin III deficiency in surgical intensive care patients. Thromb Res. 1981; 21(1-2):73-80. DOI: 10.1016/0049-3848(84)90034-3. View

Spero J, Lewis J, Hasiba U . Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost. 1980; 43(1):28-33. View

NEAME P, Kelton J, Walker I, STEWART I, Nossel H, Hirsh J . Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood. 1980; 56(1):88-92. View

Clauss A . [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol. 1957; 17(4):237-46. DOI: 10.1159/000205234. View

OBrien J, Etherington M, Pashley M . Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis. Thromb Haemost. 1984; 51(3):354-7. View

Davis R, Johnson M . Effects of bacterial endotoxin and platelet activating factor (PAF) on human platelet aggregation in native whole blood. Thromb Res. 1986; 44(5):565-73. DOI: 10.1016/0049-3848(86)90159-3. View

Jespersen J, Rasmussen N, Toftgaard C . Observations during the treatment with antithrombin-III concentrate of a case of a tampon-related toxic shock syndrome and disseminated intravascular coagulation. Discrepancies between functional and immunologic determinations of antithrombin. Thromb Res. 1982; 26(6):457-62. DOI: 10.1016/0049-3848(82)90317-6. View

10.

MacVittie T, Walker R . Hematologic responses induced by endotoxin in normal and endotoxin tolerant dogs. Exp Hematol. 1980; 8(5):599-609. View

11.

Lammle B, Tran T, Ritz R, DUCKERT F . Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). Am J Clin Pathol. 1984; 82(4):396-404. DOI: 10.1093/ajcp/82.4.396. View

12.

Hawiger J, Hawiger A, Steckley S, Timmons S, Cheng C . Membrane changes in human platelets induced by lipopolysaccharide endotoxin. Br J Haematol. 1977; 35(2):285-99. DOI: 10.1111/j.1365-2141.1977.tb00585.x. View

13.

Dawes J, Pumphrey C, McLaren K, Prowse C, Pepper D . The in vivo release of human platelet factor 4 by heparin. Thromb Res. 1982; 27(1):65-76. DOI: 10.1016/0049-3848(82)90279-1. View

14.

Tanaka H, Kobayashi N, Maekawa T . Studies on production of antithrombin III with special reference to endotoxin-induced DIC in dogs. Thromb Haemost. 1986; 56(2):137-43. View

15.

Stuart M . Effect of endotoxin on arachidonic acid release and thromboxane B2 production by human platelets. Am J Hematol. 1981; 11(2):159-64. DOI: 10.1002/ajh.2830110207. View

16.

Tanaka H, Kobayashi N, Maekawa T . Effect of thrombin and endotoxin on the in vivo metabolism of antithrombin III (AT III) in dogs. Thromb Res. 1985; 40(3):291-306. DOI: 10.1016/0049-3848(85)90265-8. View

17.

Kaplan K, Owen J . Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood. 1981; 57(2):199-202. View